Use of Electrocardiographic Screening to Clear Athletes for Return to Sports Following COVID-19 Infection
- PMID: 33585801
- PMCID: PMC7869682
- DOI: 10.1016/j.mayocpiqo.2021.01.007
Use of Electrocardiographic Screening to Clear Athletes for Return to Sports Following COVID-19 Infection
Abstract
Objective: To quantify the occurrence rate of abnormal electrocardiographic (ECG) findings and symptoms following coronavirus disease 2019 (COVID-19) infection.
Patients and methods: In this retrospective analysis, we studied adult patients (>18 years old) who were participating in collegiate athletics and previously tested positive for COVID-19 between August 1, 2020, and December 30, 2020. The athletes underwent general examinations and ECG screening prior to being medically cleared for a return to sports following their COVID-19 diagnosis. Predetermined predictors were grouped into categorical variables including (1) sex, (2) symptom severity, and (3) body mass index (normal vs overweight [≥24 kg/m2]). These variables were used to examine differences of abnormal rates that occurred between different predictor categories.
Results: Of the 170 athletes screened, 6 (3.5%) presented with abnormal ECG findings and were referred to cardiologists. We found no evidence that sex, symptom severity, and body mass index category were associated with a higher rate of abnormal ECG findings (all P>.05). Greater severity of COVID-19 symptoms was associated with a higher percentage of ST depression, T-wave inversion, ST-T changes, and the presence of fragmented QRS complex. Loss of smell, loss of taste, headache, and fatigue were the most prevalent symptoms, with 38.8% (66), 36.5% (62), 32.9% (56), and 25.3% (43), respectively, of the 170 athletes reporting each symptom.
Conclusion: Preliminary findings indicate a low risk of myocardial injury secondary to COVID-19 infection, with less than 4% of the 170 patients in our study presenting with abnormal ECG findings and a total of 16 patients (9.4%) requiring referral to a cardiologist. Although viral myocarditis was not detected in any athlete referred for cardiological assessment, 2 patients experienced effusive viral pericarditis.
Keywords: BMI, body mass index; COVID-19, coronavirus disease 2019; ECG, electrocardiography; NCAA, National Collegiate Athletic Association.
© 2021 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc.
References
-
- Jorstad H.T., van den Aardweg J.G. Balancing act: when is an elite athlete who has had COVID-19 safe to return to play? when does prudent investigation go offside into overmedicalising [editorial]? Br J Sports Med. 2020;54(19):1134–1135. - PubMed
-
- Centers for Disease Control and Prevention COVID Data Tracker: Demographic trends of COVID-19 cases and deaths in the US reported to CDC. Updated February 25, 2021. https://covid.cdc.gov/covid-data-tracker/#demographics
-
- Kim J.H., Levine B.D., Phelan D., et al. Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play. JAMA Cardiol. 2021;6(2):219–227. - PubMed
-
- Halle M., Binzenhöfer L., Mahrholdt H., Schindler M.J., Esefeld K., Tschöpe C. Myocarditis in athletes: a clinical perspective. https://doi.org/10.1177/2047487320909670 [published online ahead of print March 3, 2020]. Eur J Prev Cardiol. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources